1. Home
  2. PLSE vs BHVN Comparison

PLSE vs BHVN Comparison

Compare PLSE & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$27.44

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

BHVN

Biohaven Ltd.

HOLD

Current Price

$15.48

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
BHVN
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
PLSE
BHVN
Price
$27.44
$15.48
Analyst Decision
Buy
Buy
Analyst Count
1
14
Target Price
$22.00
$29.08
AVG Volume (30 Days)
344.9K
4.0M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$840.00
N/A
Revenue Next Year
$287.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.56
$7.48
52 Week High
$31.00
$18.57

Technical Indicators

Market Signals
Indicator
PLSE
BHVN
Relative Strength Index (RSI) 53.57 66.16
Support Level $23.94 $14.44
Resistance Level $27.82 $16.74
Average True Range (ATR) 1.72 1.05
MACD 0.02 0.02
Stochastic Oscillator 42.03 69.73

Price Performance

Historical Comparison
PLSE
BHVN

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: